]>
IRCT20171102037181N1 IRCT 2018-01-21 Zanjan University of Medical Sciences Efficacy of Neurofeedback treatment on Anxiety NT Efficacy of QEEG Guided Neurofeedback treatment on decreasing symptoms and signs of Generalized Anxiety Disorder and emotion regulation strategies. 2018-01-31 anticipated 30 Complete https://irct.ir/trial/28599 interventional Randomization: Not randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment. 3 Generalized Anxiety Disorder. Intervention group: 15 subjects will be treated on the basis of QEEG-based neurofeedback training, and 15 subjects will not receive any intervention in the control group, and individual treatment will be followed for subjects in the QEEG-based neurofeedback treatment group.. No - There is not a plan to make this available Justification or reason for not sharing IPD is In the consent form, personal information will be confidential and the data will be published by the general and a group of members.
public Hasan Abdiyan Kalibar
Eastern Side of Shahid Beheshti Hospital-Ork Gate
zanjan Iran (Islamic Republic of) 56184- 45139 +98 24 3354 2401 h.abdiyan25@yahoo.com Zanjan University of Medical Sciences scientific Hasan Abdiyan Kalibar
Eastern Side of Shahid Beheshti Hospital-Ork Gate
zanjan Iran (Islamic Republic of) 56184- 45139 +98 24 3354 2401 h.abdiyan25@yahoo.com Zanjan University of Medical Sciences Iran (Islamic Republic of) Having DSM-5 diagnostic criteria for generalized anxiety disorder diagnosed by a psychiatrist based on diagnostic interview and clinical psychologist; as well as on the basis of the 7-item GAD-7 questionnaire and DSM-5 Clinical Interview for generalized Anxiety Disorder At least 18 years and maximum 50 years Study at one of the academic levels Patient agrees to participate in research and sign a written consent 18 years 50 years Both Suffering Psychotic disorder And Substance Abuse Based on Diagnostic Interview. Not receiving psychological treatment at least 6 months before entering the research. No drug use at least one month before entering the research. Having complete criteria for personality disorder in axis II based on diagnostic interview. The apparent risk of suicide is now. Having more than two absentee sessions. F41.1 Generalized anxiety disorder Treatment - Devices Intervention group: 15 subjects will be treated on the basis of QEEG-based neurofeedback training, and 15 subjects will not receive any intervention in the control group, and individual treatment will be followed for subjects in the QEEG-based neurofeedback treatment group. The severity of the signs and symptoms of generalized anxiety disorder. Timepoint: The effect of neurofeedback treatment in patients with generalized anxiety disorder before, after and three months after treatment. Method of measurement: The score that the subject gained from the GAD-7 questionnaire is the GAD-7. This scale has been developed to diagnose anxiety disorder and to measure the severity of clinical symptoms. Emotional regulation. Timepoint: Evaluating the improvement of emotional regulation strategies before, after and three month following the treatment of neurofeedback. Method of measurement: The score for the subject of the Emotional Regulation Strategies Questionnaire (ERQ; Grass & John, 2003) was designed to evaluate two emotion regulation strategies, including suppression and re-evaluation. This questionnaire has 10 sentences. Anxiety. Timepoint: Evaluation before, after, and in the following three months. Method of measurement: The score that the subject obtained from the Depression, Anxiety and Stress Questionnaire (DASS). Depending on the DSM-5 criteria, depression involves a number of disorders that all agree on three types of symptoms: mood symptoms that include: feeling sad, empty, worrying and irritable. Vegetative symptoms that include fatigue, social deprivation and diabetes. Disturbances in appetite (depression or increased sleep) are also common. The cognitive symptoms of these disorders include centralized problems, difficulty in resolving, low self confidence, negative thoughts about oneself, the world, and others, and guilty and suicidal ideation. Timepoint: Evaluation before, after, and in the following three months. Method of measurement: The score that the subject obtained from the Depression, Anxiety and Stress Questionnaire (DASS). Zanjan University of Medical Sciences Approved 2017-09-11 Zanjan University of Medical Sciences Ethics Committee. Central Station of Zanjan University of Medical Sciences-Beginning of the Islamic Republic Boulevard-Azadi Square. zanjan Zanjan Iran (Islamic Republic of)